Meeting of the Advisory Committee on Breast Cancer in Young Women, 63433 [2024-17219]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 150 / Monday, August 5, 2024 / Notices
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, and the Secretary,
Department of Health and Human
Services, regarding (1) the practice of
healthcare infection prevention and
control; (2) strategies for surveillance,
prevention, and control of infections,
antimicrobial resistance, and related
events in settings where healthcare is
provided; and (3) periodic updating of
CDC guidelines and other policy
statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda
will include the following updates: The
Healthcare Personnel Guideline
Workgroup; Isolation Precautions
Guideline Workgroup; Dental Unit
Waterlines Guideline Update; Division
of Health Quality Promotion Updates;
Review of Viral Hemorrhagic Fever
Update; Pathogen Reduction Guidance
Introduction; NHSN Update;
Recommendation Categorization
Framework Update. Agenda items are
subject to change.
lotter on DSK11XQN23PROD with NOTICES1
Public Participation
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment.
Priority will be given to individuals
who submit a request to make an oral
public comment before the meeting
according to the procedures below. All
persons interested in making an oral
public comment at the August 22, 2024
HICPAC meeting must submit a request
between July 26, 2024, and August 12,
2024, at https://www.cdc.gov/hicpac/
meeting.html no later than 11:59 p.m.,
EDT, August 12, 2024, according to the
instructions provided on the HICPAC
website. If the number of persons
requesting to speak is greater than can
be reasonably accommodated during the
scheduled time, CDC will conduct a
lottery to determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
by August 17, 2024.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
18:38 Aug 02, 2024
Jkt 262001
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–17220 Filed 8–2–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Advisory Committee on
Breast Cancer in Young Women
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting of the Advisory
Committee on Breast Cancer in Young
Women (ACBCYW). This meeting is
open to the public, limited only by
conference room space and web
Conference lines (40 conference room
and 60 web conference participant
spaces available). Online registration is
required.
DATES: The meeting will be held on
September 13, 2024, from 8:30 a.m. to
4 p.m., EDT.
ADDRESSES: 4770 Buford Highway,
Atlanta, Georgia 30341, Building 106,
Room 1B. All ACBCYW Meeting
participants must register for the
meeting online at least 5 business days
in advance at https://www.cdc.gov/
breast-cancer/php/advisory-committee/
index.html. Please complete all the
required fields and submit your
registration no later than September 6,
2024. Registered participants will
receive access instructions before the
meeting. All visitors are required to
present a valid form of picture
identification issued by a state, federal
or international government. As
required by the Federal Property
Management Regulations, all persons
entering in or on Federal controlled
property and their packages, briefcases,
and other containers in their immediate
possession are subject to being x-rayed
and inspected. Federal law prohibits the
knowing possession or the causing to be
present of firearms, explosives and other
dangerous weapons and illegal
substances. Time will be available for
public comment. The public is welcome
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 9990
63433
to submit written comments in advance
of the meeting. Comments should be
submitted in writing by email to
acbcyw@cdc.gov. The deadline for
receipt is September 10, 2024.
FOR FURTHER INFORMATION CONTACT:
Kimberly E. Smith, M.B.A., M.H.A.,
Designated Federal Officer, Advisory
Committee on Breast Cancer in Young
Women, National Center for Chronic
Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway
NE, Mailstop S107–4, Atlanta, Georgia
30341. Telephone: (404) 498–0073; Fax:
(770) 488–4760; Email: acbcyw@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee
provides advice and guidance to the
Secretary, HHS; the Assistant Secretary
for Health; and the Director, CDC,
regarding the formative research,
development, implementation, and
evaluation of evidence-based activities
designed to prevent breast cancer
(particularly among those at heightened
risk) and promote the early detection
and support of young women who
develop the disease. The advice
provided by the Advisory Committee
will assist in ensuring scientific quality,
timeliness, utility, and dissemination of
credible appropriate messages and
resource materials.
Matters to be Considered: The agenda
will include discussions on current
topics related to breast cancer in young
women. These will include Mental/
Behavioral Health, Sexual Health,
Genetics and Genomics, and Provider
Engagement. Agenda items are subject
to change as priorities dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–17219 Filed 8–2–24; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\05AUN1.SGM
05AUN1
]]>Agencies
[Federal Register Volume 89, Number 150 (Monday, August 5, 2024)]
[Notices]
[Page 63433]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-17219]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Advisory Committee on Breast Cancer in Young Women
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting of the Advisory Committee on Breast Cancer in Young
Women (ACBCYW). This meeting is open to the public, limited only by
conference room space and web Conference lines (40 conference room and
60 web conference participant spaces available). Online registration is
required.
DATES: The meeting will be held on September 13, 2024, from 8:30 a.m.
to 4 p.m., EDT.
ADDRESSES: 4770 Buford Highway, Atlanta, Georgia 30341, Building 106,
Room 1B. All ACBCYW Meeting participants must register for the meeting
online at least 5 business days in advance at https://www.cdc.gov/breast-cancer/php/advisory-committee/. Please complete all
the required fields and submit your registration no later than
September 6, 2024. Registered participants will receive access
instructions before the meeting. All visitors are required to present a
valid form of picture identification issued by a state, federal or
international government. As required by the Federal Property
Management Regulations, all persons entering in or on Federal
controlled property and their packages, briefcases, and other
containers in their immediate possession are subject to being x-rayed
and inspected. Federal law prohibits the knowing possession or the
causing to be present of firearms, explosives and other dangerous
weapons and illegal substances. Time will be available for public
comment. The public is welcome to submit written comments in advance of
the meeting. Comments should be submitted in writing by email to
[email protected]. The deadline for receipt is September 10, 2024.
FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, M.B.A., M.H.A.,
Designated Federal Officer, Advisory Committee on Breast Cancer in
Young Women, National Center for Chronic Disease Prevention and Health
Promotion, Centers for Disease Control and Prevention, 4770 Buford
Highway NE, Mailstop S107-4, Atlanta, Georgia 30341. Telephone: (404)
498-0073; Fax: (770) 488-4760; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee provides advice and guidance to the
Secretary, HHS; the Assistant Secretary for Health; and the Director,
CDC, regarding the formative research, development, implementation, and
evaluation of evidence-based activities designed to prevent breast
cancer (particularly among those at heightened risk) and promote the
early detection and support of young women who develop the disease. The
advice provided by the Advisory Committee will assist in ensuring
scientific quality, timeliness, utility, and dissemination of credible
appropriate messages and resource materials.
Matters to be Considered: The agenda will include discussions on
current topics related to breast cancer in young women. These will
include Mental/Behavioral Health, Sexual Health, Genetics and Genomics,
and Provider Engagement. Agenda items are subject to change as
priorities dictate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-17219 Filed 8-2-24; 8:45 am]
BILLING CODE 4163-18-P
